SAN DIEGO–(BUSINESS WIRE)–$BIIB #BIIB—Robbins LLP reminds investors that a shareholder filed a class action on behalf…
Continue ReadingEtiqueta: Business Wire
Oregon Jury Awards $260 Million in Mesothelioma Case Against Johnson & Johnson
Dean Omar Branham Shirley secures verdict on behalf of mother diagnosed with mesothelioma PORTLAND, Ore.–(BUSINESS WIRE)–A…
Continue Reading
Mitsubishi Electric to Ship Samples of 16W GaN Power Amplifier Module for 5G Massive MIMO Base Stations
Deployment in 32T32 massive MIMO antennas will lower production costs and reduce base station power consumption…
Continue Reading
LambdaTest Introduces Test Manager for Streamlined Test Management
Test Manager aims to enhance productivity, collaboration, and efficiency in test management by providing a centralized,…
Continue Reading
Septerna Presents Preclinical Data at ENDO 2024 Highlighting Therapeutic Potential of its GPCR Drug Discovery Platform
Oral, small molecule parathyroid hormone 1 receptor (PTH1R) agonist maintained serum calcium control over 28-day dosing…
Continue Reading
American Lending Center Celebrates 15 Years Of Growth
IRVINE, Calif.–(BUSINESS WIRE)–American Lending Center, a private non-bank lending institution nationally recognized for both small business…
Continue Reading
OKI Signs Partnership Agreement with US-based Plug and Play
–Commencing global open innovation activities based in Silicon Valley– TOKYO–(BUSINESS WIRE)–OKI (TOKYO: 6703) has signed an…
Continue Reading
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
First and only EGFR inhibitor and targeted treatment to show benefit in Stage III setting, extending…
Continue Reading
CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated with Visugromab/Nivolumab Combination
The results include data from three main study cohorts: In the non-squamous non-small cell lung cancer…
Continue Reading
Stronger Than Ever: Adani Portfolio Delivers Record Performance
45% EBITDA growth in FY24, EBITDA reaches USD 10 Bn Adani Portfolio EBITDA increased to USD…
Continue Reading